Glucagon-Like Peptide 1 (GLP-1) Agonist Market To Reach USD 21.2 Billion By 2032, Report By DataHorizzon Research Fort Collins, Colorado, April 08, 2024 (GLOBE NEWSWIRE) -- Growing cases of diabetes and obesity trigger the need for GLP-1 receptor agonists Type 2 diabetes and obesity represent critical health...